Elizaveta Korobova

Ms. Elizaveta Korobova


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
TOTatiana Andreevna Ozharovskaia
Tatiana Andreevna Ozharovskaia
OZOlga V. Zubkova
Olga V. Zubkova
EKElizaveta Korobova
Elizaveta Korobova
ISInna Shuliakova
Inna Shuliakova
DZDenis I. Zrelkin
Denis I. Zrelkin
AGAlexander L. Gintsburg
Alexander L. Gintsburg
Background/Objectives: Flaviviruses, including West Nile virus (WNV), pose global health challenges due to their worldwide distribution, pathogenicity, and lack of effective treatments or vaccines. Today, WNV is considered the most important causative agent of viral encephalitis worldwide. This study investigated the different forms of the main WNV antigen—the preM/E protein—in the context of its immunogenic and protective properties. Methods: The recombinant adenovirus type 2 (rAd2) vectors expressing different forms of the WNV preM/E genes were obtained using standard molecular biology techniques. Immunogenicity in mice was assessed by enzyme-linked immunosorbent assay (ELISA) and virus neutralization assay. Immunological efficacy was evaluated in a mouse viral challenge model. Results: The rAd2 vector expressing the West Nile virus preM/E gene with mutations in the fusion loop exhibited robust immunogenicity when administered intramuscularly either once or in a homologous prime-boost regimen. This antigen form, as part of an adenoviral vector, protected mice from death in viral challenge experiments, providing 100% survival following WNV challenge. Conclusions: We believe that a vaccination strategy involving a recombinant adenoviral vector based on human adenovirus type 2 and the WNV antigen represented by the preM/E gene with mutations in the fusion loop may be a promising approach for combating West Nile virus infection.

22 April 2024 in Molecular Genetics Microbiology and Virology (Russian version)
Verified
Journal Article
Closed access
OZO.V. Zubkova
O.V. Zubkova
TOTatiana Andreevna Ozharovskaia
Tatiana Andreevna Ozharovskaia
OPOlga Popova
Olga Popova
EKElizaveta Korobova
Elizaveta Korobova
PGPolina Goldovskaya
Polina Goldovskaya
DSDmitry Shcheblyakov
Dmitry Shcheblyakov
This work highlights the importance of a target gene sequence optimization in vaccine development. The purpose of the study was to compare the immunogenicity of recombinant adenoviruses expressing the S protein gene of the SARS-CoV-2 virus variant Omicron (BA.5.3.1) with an optimized nucleotide sequence (Ad5-S-BA5opt) or non-optimized (Ad5-S-BA5). Material and methods. Recombinant adenoviruses were grown on HEK293 cell culture; purification was carried out by ultracentrifugation in a stepwise density gradient of CsCl. The resulting adenovirus samples were characterized by authenticity (by real-time PCR (RT-PCR) and immunoblotting), the number of viral particles (using spectrophotometry) and infectious titer (using the end-point dilution (TCD50) method). The titer of RBD-specific IgG antibodies in an animal model was assessed by enzyme-linked immunosorbent assay (ELISA). Results. Based on the results of studies in an animal model, a vector expressing the optimized gene (Ad5-S-BA5opt) led to the formation of higher levels of IgG-specific antibodies compared to a similar vector containing the wild-type protein gene. Particularly interesting is the fact that an approach aimed solely at optimizing the sequence of the target gene, and not other components of the vector, can make significant changes in the immunogenicity of the vector. Conclusion. The obtained results are important for the development of new, more effective strategies for creating vaccines and gene therapy drugs. Optimization of the nucleotide sequence can lead to an improved mRNA stability and a significant increase in the expression of the target gene, and as a result, a significant increase in the protective properties of the candidate drug. This method can be assumed to become promising for the development of vaccines against viruses containing low-immunogenic antigens.

1 June 2026 in Molecular Genetics, Microbiology and Virology
Verified
Journal Article
Closed access
PDF file
DSD. A. Shein
D. A. Shein
DSD.N. Shcherbinin
D.N. Shcherbinin
EKElizaveta Korobova
Elizaveta Korobova
PGPolina Goldovskaya
Polina Goldovskaya
ACA. S. Chugunova
A. S. Chugunova
OZO. V. Zubkova
O. V. Zubkova
Adenovirus vector vaccines became an important class of vaccines following their approval for the prevention of Ebola virus fever and COVID-19. Quality dat

1 December 2024 in Molecular Genetics, Microbiology and Virology
Verified
Journal Article
Closed access
PDF file
OZO. V. Zubkova
O. V. Zubkova
TOTatiana Andreevna Ozharovskaia
Tatiana Andreevna Ozharovskaia
OPOlga Popova
Olga Popova
EKElizaveta Korobova
Elizaveta Korobova
PGPolina Goldovskaya
Polina Goldovskaya
DSDmitry Shcheblyakov
Dmitry Shcheblyakov
This work highlights the importance of nucleotide sequence optimization of a target gene in the development of vaccines. The purpose of the study was to co

23 November 2023 in Polymers
Verified
Journal Article
Open access
PDF file
MLMaxim D. Lisowski
Maxim D. Lisowski
EKElizaveta Korobova
Elizaveta Korobova
ANAlina O. Naumova
Alina O. Naumova
ISIgor P. Sedishev
Igor P. Sedishev
AMAlina A. Markova
Alina A. Markova
Pavel MelnikovPavel Melnikov
Pavel Melnikov
The use of biocidal agents is a common practice for protection against biofouling in biomass-rich environments. In this paper, oligohexamethyleneguanidine (OHMG) polymer, known for its biocidal properties, was further modified with para-aminosalicylic acid (PAS) to enhance its properties against microorganisms coated with a lipid membrane. The structure of the product was confirmed by 1H NMR, 13C NMR, and FTIR spectroscopy. The values of the minimum inhibitory concentration (MIC) against Mycobacterium smegmatis ATCC 607 and Pseudomonas chlororaphis 449 were found to be 1.40 and 1.05 μg/mL, respectively. The synthesized substance was used as an additive to the polymer matrix of the composite optical oxygen sensor material. A series of samples with different contents of OHMG-PAS was prepared using a co-dissolution method implying the fabrication of a coating from a solution containing both polymers. It turned out that the mutual influence of the components significantly affects the distribution of the indicator in the matrix, surface morphology, and contact angle. The optimal polymer content turned out to be wt.3%, at which point the water contact angle reaches almost 122°, and the fouling rate decreases by almost five times, which is confirmed by both the respiratory MTT assay and confocal microscopy with staining. This opens up prospects for creating stable and biofouling-resistant sensor elements for use in air tanks or seawater.